Angelman Syndrome Alliance

The Angelman Syndrome Alliance (ASA) is a partnership of small organizations from around the world that are focused on supporting people with Angelman Syndrome.

[Angelman Syndrome Alliance @alliance12768]

Launch of the ASA Grant 2024 to fund research into Angelman syndrome.
https://t.co/Nx6rof4Ajg
#angelmansyndrome #angelman #grantcall

[Angelman Syndrome Alliance @alliance12768]

We are proud to announce the 2026 Research Grant winners — three projects, three therapeutic frontiers:
- Gut–brain axis & probiotics — Dr. Carmen De Caro
- UBE3A protein homeostasis — Prof. Ype Elgersma
- Next-gen ASO delivery — Prof. Ben Philpot

Congratulations to all three!

[Angelman Syndrome Alliance @alliance12768]

⏰ Last Call – ASA Grant 2026
Final submissions for our 6th international grant call on Angelman Syndrome.
💶Up to €120,000 – max 3 years
🌍Open worldwide
📅Deadline: November 1, 2025
https://t.co/Ax1EmZpS3b

[Angelman Syndrome Alliance @alliance12768]

8th ASA scientific conference on Angelman Syndrome Coventry (UK) on 1st & 2nd August, 2024 brought together top specialists and researchers from around the world, fostering an environment of collaboration and innovation. #angelmansyndrome Read more on https://t.co/A6r4P11CAr

[Angelman Syndrome Alliance @alliance12768]

Today it is International Angelman Syndrome Awareness Day. As ASA our mission today and always is to grow and support scientific knowledge about AS that can create fundamental and lasting changes in therapy for people with AS.
#AngelmanSyndromeAwareness

[Angelman Syndrome Alliance @alliance12768]

Angelman Syndrome Alliance announces new grant winners for 2024:
Matteo Fossati -"Investigation of genetic determinants of AS pathophysiology in human neurons".
Carmen de Caro - "The gut microbiota in AS".
Ramiro de Almeida -"A drug repurposing strategy to treat AS"